Montana Cancer Institute Foundation

Missoula, Montana 59802

0 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Carcinoma, Small Cell, Chronic Lymphocytic Leukemia, Intractable Pain, Multiple Myeloma, Neoplasms, Neoplasms, Unknown Primary, Pancreatic Adenocarcinoma, Prostate Cancer Early Risk Treated by Radiosurgery, Prostate Cancer Intermediate Risk Treated by Radiosurgery

Studies at this site

• Connect® MM- The Multiple Myeloma Disease Registry — Stopped early
• Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma — Completed
• Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry — Completed
• Multi-Institutional Registry for Prostate Cancer Radiosurgery — Status unconfirmed
• A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer — Completed
• NP2 Enkephalin For Treatment of Intractable Cancer Pain — Completed
• Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site — Completed
• Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer — Completed